Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 23, 1998
Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats
M Thierry-Palmer, K S Carlyle, M D Williams, et al.
Infection
|
May 1, 2009
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry
R Beale, K Reinhart, F M Brunkhorst, et al.
Anti-Cancer Drug Design
|
June 17, 1998
Antineoplastic agents 365. Dolastatin 10 SAR probes
G R Pettit, J K Srirangam, J Barkoczy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
E Massarelli, H Lin, L E Ginsberg, et al.
Oral Oncology
|
July 27, 2025
The biological mechanisms underpinning nutritional and health-related consequences of mucositis in head and neck cancer - A review
Caelleb R Morcom, Connor M D Williams, Ghanyah Al-Qadami, et al.
British Journal of Haematology
|
September 12, 2023
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma
Connor M D Williams, Jacqueline E Noll, Alanah L Bradey, et al.
Pediatric Hematology and Oncology
|
February 5, 1999
Pediatric oncology and hematology in Birmingham, England
J R Mann, P J Darbyshire, A Goodman, et al.
The Pharmacogenomics Journal
|
February 8, 2012
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis
M Man, S L Close, A D Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
R I Haddad, E Massarelli, J J Lee, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 23, 1998
Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats
M Thierry-Palmer, K S Carlyle, M D Williams, et al.
Infection
|
May 1, 2009
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry
R Beale, K Reinhart, F M Brunkhorst, et al.
Anti-Cancer Drug Design
|
June 17, 1998
Antineoplastic agents 365. Dolastatin 10 SAR probes
G R Pettit, J K Srirangam, J Barkoczy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
E Massarelli, H Lin, L E Ginsberg, et al.
Oral Oncology
|
July 27, 2025
The biological mechanisms underpinning nutritional and health-related consequences of mucositis in head and neck cancer - A review
Caelleb R Morcom, Connor M D Williams, Ghanyah Al-Qadami, et al.
British Journal of Haematology
|
September 12, 2023
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma
Connor M D Williams, Jacqueline E Noll, Alanah L Bradey, et al.
Pediatric Hematology and Oncology
|
February 5, 1999
Pediatric oncology and hematology in Birmingham, England
J R Mann, P J Darbyshire, A Goodman, et al.
The Pharmacogenomics Journal
|
February 8, 2012
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis
M Man, S L Close, A D Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
R I Haddad, E Massarelli, J J Lee, et al.
Page
of 18